Magnesium glycerophosphate 97.2mg (4mmol) chewable tablets reclassified as a special container

Following representations from PSNC, the Department of Health of Social Care (DHSC) has re-determined the special container status of a Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets. From August 2022, this product has been added to Part VIII of the Drug Tariff with special container status as it meets the relevant criteria as set out [...]

The post Magnesium glycerophosphate 97.2mg (4mmol) chewable tablets reclassified as a special container appeared first on PSNC Website.